The relationship between colorectal cancer and type 2 diabetes mellitus in gut microbiota

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900023391

Enrollment

Unknown

Registered

2019-05-25

Start date

2017-09-01

Completion date

Unknown

Last updated

2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

T2DM:collect feces

normal:collect feces

colorectal cancer:collect feces

DCRC:collect feces

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) all patients were hospitalized and underwent fibrocolonoscopy; (2) pathological diagnosis of adenocarcinoma and mucinous adenocarcinoma; (3) preoperative cTNM clinical staging was performed; (4) all colorectal cancer patients received surgical treatment; (5) pTNM staging was performed postoperatively.

Exclusion criteria

Exclusion criteria: (1) familial adenomatous polyposis; (2) Lynch syndrome; (3) anal and perianal carcinoma; (4) patients with colorectal cancer complicated with severe cardiovascular and cerebrovascular disease and multiple organ failure; (5) recurrence of colorectal cancer; (6) with smoking or drinking habits; (7) with history of antibiotic use in the past 3 months.

Design outcomes

Primary

Measure	Time frame
gut microbiota;blood routine examination;blood biochemistry;Tumor marker;Immune microenvironment;	—

Countries

China

Contacts

Public ContactGu Jin

Shougang Hospital, Peking University

zlgujin@126.com+86 13801180717

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026